UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

The lancet oncology, 2013-09, Vol.14 (10), p.1020-1026

2013

Link zum Volltext

Verfügbarkeit prüfen

Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve

World journal of surgical oncology, 2021-12, Vol.19 (1), p.347-347, Article 347

2021

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve

World journal of surgical oncology, 2022-02, Vol.20 (1), p.49-49, Article 49

2022

Link zum Volltext

Verfügbarkeit prüfen

Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells

Oncology reports, 2016-02, Vol.35 (2), p.992-998

2016

Link zum Volltext

Verfügbarkeit prüfen

Profiling analysis of circulating microRNA expression in cervical cancer

Molecular and clinical oncology, 2016-07, Vol.5 (1), p.189-194

2016

Link zum Volltext

Verfügbarkeit prüfen

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

Journal of Gynecologic Oncology, 2020, 31(6), , pp.1-12

2020

Link zum Volltext

Verfügbarkeit prüfen

A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix

International journal of clinical oncology, 2014-12, Vol.19 (6), p.1059-1064

2014

Link zum Volltext

Verfügbarkeit prüfen

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

International journal of clinical oncology, 2014-12, Vol.19 (6), p.1074-1079

2014

Link zum Volltext

Verfügbarkeit prüfen

Early growth response‐1 mediates downregulation of telomerase in cervical cancer

Cancer science, 2008-07, Vol.99 (7), p.1401-1406

2008

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factor on optimal debulking surgery by maximum effort for stage IIIC epithelial ovarian cancer

The journal of obstetrics and gynaecology research, 2009-04, Vol.35 (2), p.315-319

2009

Link zum Volltext

Verfügbarkeit prüfen

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

Journal of clinical oncology, 2016-08, Vol.34 (24), p.2881-2887

2016

Link zum Volltext

Verfügbarkeit prüfen

A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology

The journal of obstetrics and gynaecology research, 2009-06, Vol.35 (3), p.588-592

2009

Link zum Volltext

Verfügbarkeit prüfen

Strategies and techniques for resection of upper abdominal disease in patients with advanced ovarian cancer

Nihon rinshō, 2012-06, Vol.70 Suppl 4, p.576

Terauchi, Fumitoshi

2012

Link zum Volltext

Verfügbarkeit prüfen

Strategies for marginally resectable tumor in patients with advanced ovarian cancer

Gan to kagaku ryoho, 2011-08, Vol.38 (8), p.1261

Terauchi, Fumitoshi

2011

Link zum Volltext

Verfügbarkeit prüfen

Krüppel-like factor 5 is upregulated and induces cell proliferation in endometrial cancer

Oncology letters, 2021-06, Vol.21 (6), p.484-484, Article 484

2021

Link zum Volltext

Verfügbarkeit prüfen

Pathological Characterization of Ovarian Cancer Patients Who Underwent Debulking Surgery in Combination With Diaphragmatic Surgery: A Cross-Sectional Study

Medicine (Baltimore), 2015-12, Vol.94 (50), p.e2296-e2296

2015

Link zum Volltext

Verfügbarkeit prüfen

Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer

Human reproduction (Oxford), 2007-07, Vol.22 (7), p.1953-1958

2007

Link zum Volltext

Verfügbarkeit prüfen

The prognosis of patients with recurrent or persistent ovarian clear cell carcinoma: Results from a randomized phase III study (JGOG3017/GCIG)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.5515-5515

2019

Link zum Volltext

Verfügbarkeit prüfen

Sclerosing stromal tumor of the ovary with elevated CA125

The journal of obstetrics and gynaecology research, 2005-10, Vol.31 (5), p.432-435

2005

Link zum Volltext

Verfügbarkeit prüfen

Weekly docetaxel for patients with platinum/paclitaxel/irinotecan-resistant relapsed ovarian cancer: a phase I study

International journal of clinical oncology, 2003-12, Vol.8 (6), p.348-351

2003

Link zum Volltext

Verfügbarkeit prüfen

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

Journal of gynecologic oncology, 2020-11, Vol.31 (6), p.1-12

2020

Link zum Volltext

Verfügbarkeit prüfen

Exosomal-miRNA profiles as diagnostic biomarkers in cervical cancer

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.10557-10557

2012

Link zum Volltext

Verfügbarkeit prüfen

Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm

International journal of clinical oncology, 2002-12, Vol.7 (6), p.356-360

2002

Link zum Volltext

Verfügbarkeit prüfen

Long-term follow-up of a randomized trial comparing conventional paclitaxel and carboplatin with dose-dense weekly paclitaxel and carboplatin in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: JGOG 3016 trial

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.5003-5003

2012

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.5507-5507

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(37)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Female
(24)
Humans
(24)
Life Sciences & Biomedicine
(20)
Science & Technology
(20)
Oncology
(15)
Ovarian Neoplasms - Pathology
(13)
Ovarian Cancer
(11)
Adult
(10)
Middle Aged
(10)
Aged
(8)
Neoplasm Staging
(8)
Obstetrics & Gynecology
(8)
Ovarian Neoplasms - Surgery
(7)
Paclitaxel - Administration & Dosage
(7)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(6)
Carboplatin - Administration & Dosage
(5)
Chemotherapy
(5)
Ovarian Neoplasms - Drug Therapy
(5)
Prognosis
(5)
Cancer Research
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial

Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve

Correction to: Introduction of gasless laparoscopic surgery as a minimally invasive procedure for endometrial cancer and its usefulness from the viewpoint of the learning curve

Hypoxia inducible factor-1 mediates upregulation of urokinase-type plasminogen activator receptor gene transcription during hypoxia in cervical cancer cells

Profiling analysis of circulating microRNA expression in cervical cancer

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

A retrospective study of urokinase-type plasminogen activator receptor (uPAR) as a prognostic factor in cancer of the uterine cervix

Pathology-oriented treatment strategy of malignant ovarian tumor in pregnant women: analysis of 41 cases in Japan

Early growth response‐1 mediates downregulation of telomerase in cervical cancer

Prognostic factor on optimal debulking surgery by maximum effort for stage IIIC epithelial ovarian cancer

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial

A case of advanced ovarian cancer upstaged on the bases of pleural washing cytology

Strategies and techniques for resection of upper abdominal disease in patients with advanced ovarian cancer

Strategies for marginally resectable tumor in patients with advanced ovarian cancer

Krüppel-like factor 5 is upregulated and induces cell proliferation in endometrial cancer

Pathological Characterization of Ovarian Cancer Patients Who Underwent Debulking Surgery in Combination With Diaphragmatic Surgery: A Cross-Sectional Study

Fertility-preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer

The prognosis of patients with recurrent or persistent ovarian clear cell carcinoma: Results from a randomized phase III study (JGOG3017/GCIG)

Sclerosing stromal tumor of the ovary with elevated CA125

Weekly docetaxel for patients with platinum/paclitaxel/irinotecan-resistant relapsed ovarian cancer: a phase I study

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma: results from a randomized phase III study in JGOG3017/GCIG

Exosomal-miRNA profiles as diagnostic biomarkers in cervical cancer

Combination chemotherapy with paclitaxel and intraperitoneal cisplatin for ovarian cancer with disseminated lesions in the peritoneum and the diaphragm

Long-term follow-up of a randomized trial comparing conventional paclitaxel and carboplatin with dose-dense weekly paclitaxel and carboplatin in women with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: JGOG 3016 trial

Randomized phase III trial of paclitaxel/carboplatin (PC) versus cisplatin/irinotecan (CPT-P) as first-line chemotherapy in patients with clear cell carcinoma (CCC) of the ovary: A Japanese Gynecologic Oncology Group (JGOG)/GCIG study

Suchergebnisse filtern